Venture Visionary Partners LLC Grows Stake in Lam Research Corporation $LRCX

Venture Visionary Partners LLC lifted its stake in Lam Research Corporation (NASDAQ:LRCX) by 9.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,717 shares of the semiconductor company’s stock after acquiring an additional 4,198 shares during the quarter. Venture Visionary Partners LLC’s holdings in Lam Research were worth $16,661,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in LRCX. Van ECK Associates Corp grew its stake in shares of Lam Research by 411.8% during the 2nd quarter. Van ECK Associates Corp now owns 11,089,395 shares of the semiconductor company’s stock valued at $4,805,368,000 after acquiring an additional 8,922,854 shares during the period. Bank of New York Mellon Corp bought a new stake in Lam Research during the 2nd quarter worth approximately $3,777,585,000. Corient Private Wealth LLC lifted its holdings in Lam Research by 235.5% during the fourth quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after purchasing an additional 3,649,553 shares in the last quarter. J. Stern & Co. LLP lifted its holdings in Lam Research by 3,826.9% during the fourth quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company’s stock valued at $592,176,000 after purchasing an additional 3,371,283 shares in the last quarter. Finally, Jennison Associates LLC boosted its position in shares of Lam Research by 296.9% in the first quarter. Jennison Associates LLC now owns 3,373,306 shares of the semiconductor company’s stock worth $720,740,000 after purchasing an additional 2,523,351 shares during the period. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-driven demand remains a key catalyst. Lam Research is highlighted alongside NVIDIA, Applied Materials and TSMC as a chip-industry company with dependable earnings and durable growth prospects tied to the AI boom. 4 Top Chip Stocks With Dependable Earnings to Ride the AI Boom
• Positive Sentiment: Strong earnings and margins support the investment case. Zacks says Lam’s premium valuation is supported by surging earnings, improving margins and exposure to advanced packaging, HBM and broader chipmaking demand. The company’s latest reported quarter also exceeded consensus estimates for both EPS and revenue, while management issued quarterly EPS guidance of $2.00–$2.30. Should You Invest in Lam Research Stock Despite Its Premium Valuation?
• Positive Sentiment: Analyst sentiment remains favorable. Recent coverage identifies Lam Research as a preferred semiconductor-industry name, and Morgan Stanley reportedly raised its price target, reinforcing expectations for continued upside tied to semiconductor capital spending. TSMC Stock Hits Record High, Morgan Stanley Raises Lam Research Price Target
• Neutral Sentiment: Industry outlook remains constructive. Lam Research is included in multiple semiconductor-industry reports alongside Applied Materials and FormFactor, reflecting broad expectations for sustained AI-related equipment demand. Zacks Industry Outlook Applied Materials, Lam Research and FormFactor
• Negative Sentiment: Valuation is a significant risk. Although Lam is growing faster than KLA, the companies reportedly had similar forward earnings multiples, while Lam traded at a higher valuation relative to trailing free cash flow. Investors may therefore demand continued execution to justify the premium. Lam Research vs. KLA: Is Faster Growth Worth Paying More for Cash Flow?
• Negative Sentiment: One circulating clinical-study headline appears unrelated to Lam Research’s semiconductor business. The abdominoplasty reference does not describe a credible Lam Research operating catalyst and may reflect an erroneous company attribution; investors should not treat it as material news for LRCX. New Abdominoplasty Trial Signals Steady Demand in Procedure-Driven Healthcare

Lam Research Trading Down 1.3%

NASDAQ LRCX traded down $4.38 during trading on Wednesday, hitting $329.51. The stock had a trading volume of 6,384,615 shares, compared to its average volume of 10,736,192. Lam Research Corporation has a one year low of $131.02 and a one year high of $438.50. The stock has a 50 day simple moving average of $310.02 and a 200 day simple moving average of $305.12. The stock has a market capitalization of $412.36 billion, a price-to-earnings ratio of 57.21, a P/E/G ratio of 1.37 and a beta of 1.85. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the prior year, the business posted $1.33 earnings per share. The company’s revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts predict that Lam Research Corporation will post 9.32 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. This is a positive change from Lam Research’s previous quarterly dividend of $0.26. The ex-dividend date is Wednesday, September 23rd. Lam Research’s dividend payout ratio is 22.92%.

Insider Transactions at Lam Research

In other news, Director Bethany Mayer sold 9,557 shares of the business’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $314.74, for a total transaction of $3,007,970.18. Following the completion of the sale, the director directly owned 20,995 shares of the company’s stock, valued at approximately $6,607,966.30. The trade was a 31.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Abhijit Talwalkar sold 18,282 shares of the company’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares in the company, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 32,839 shares of company stock worth $10,644,740. 0.31% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on LRCX shares. Oppenheimer reiterated an “outperform” rating and issued a $400.00 price target (up from $330.00) on shares of Lam Research in a research note on Monday, June 15th. Cantor Fitzgerald set a $500.00 price objective on Lam Research and gave the company an “overweight” rating in a research report on Monday, June 29th. Susquehanna reaffirmed a “positive” rating and issued a $475.00 price objective (up from $385.00) on shares of Lam Research in a research note on Tuesday, June 30th. UBS Group decreased their target price on Lam Research from $435.00 to $425.00 and set a “buy” rating on the stock in a research note on Tuesday, September 1st. Finally, Evercore reissued an “outperform” rating and issued a $355.00 price target on shares of Lam Research in a report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and an average price target of $364.59.

Lam Research Company Profile

Lam Research Corporation is a semiconductor equipment company that designs, manufactures, and services systems used in the fabrication of integrated circuits and other electronic devices. Its equipment supports key steps in the wafer manufacturing process, helping semiconductor producers create increasingly small and complex features on silicon wafers.

The company’s portfolio includes systems for etch, deposition, wafer cleaning, surface preparation, and related manufacturing processes.